Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have undergone a hematopoietic stem cell transplantation
You may not be if
Known or suspected allergy to trial product
Participation in other trials with unapproved drugs or trials with equal or similar objective
Clareo Health | Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation
